Sfoglia per AUTORE
GALITZIA A
Collezione AOU Città della Salute di Torino

  

Items : 6

Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience. in Hematological oncology / Hematol Oncol. 2025 Jan;43(1):e70033. doi: 10.1002/hon.70033.

2025
AOU Città della Salute di Torino

Innocenti I; Tomasso A; Giannarelli D; Scarfò L; Murru R; Visentin A; Frustaci AM; Morelli F; Vitale C; Mosca A; Sanna A; Farina G; Laureana R; Gentile M; Galitzia A; Pasquale R; Autore F; Olivieri J; Romeo A; Deodato M; Stirparo L; Corbingi A; Innao V; Perutelli F; Martini F; Sportoletti P; Fresa A; Del Principe MI; Tedeschi A; et alii...

Salvage treatment after covalent BTKi failure: An unmet need in clinical practice in Waldenstrom macroglobulinemia. in HemaSphere / Hemasphere. 2025 Feb 20;9(2):e70094. doi: 10.1002/hem3.70094. eCollection 2025 Feb.

2025
AOU Città della Salute di Torino

Frustaci AM; Zappaterra A; Galitzia A; Visentin A; Merli M; Rizzi R; Ferrarini I; Ferrero S; Innao V; Baratè C; Zinzani P; Puccini B; Autore F; Tani M; Ferrari A; Catania G; Nicolosi M; Pasquale R; Motta M; Murru R; Gambara S; Rezzonico F; Varettoni M; Cencini E; Lista E; Danesin N; Granelli BM; Deodato M; Piazza F; et alii...

Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL. in HemaSphere / Hemasphere. 2024 Sep 17;8(9):e70004. doi: 10.1002/hem3.70004. eCollection 2024 Sep.

2024
AOU Città della Salute di Torino
AOU Novara

Popov VM; Pangalis GA; Espinet B; Bosch F; Sportoletti P; Panagiotidis P; Gozzetti A; Oscier D; Zuchnicka J; Yassin M; Yañez L; Yagci M; Xu Z; Walewska R; Vukovic V; Vrachiolias G; Vitale C; Visentin A; Vassilakopoulos T; Tse E; Tomic K; Tadmor T; Stilgenbauer S; Soliman DSA; Smirnova S; Simkovic M; Shokralla T; Shen Y; Schiwitza A; et alii...

Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience. in HemaSphere / Hemasphere. 2024 Nov 28;8(12):e144. doi: 10.1002/hem3.144. eCollection 2024 Dec.

2024
AOU Città della Salute di Torino

Innocenti I; Mosca A; Tomasso A; Galitzia A; Scarfò L; Morelli F; Galli E; Martini F; Sangiorgi E; Laureana R; Benintende G; Mattiello V; Chiriu S; Del Principe MI; Zamprogna G; Gentile M; Martino EA; Cappello E; Montalbano MC; Farina G; Innao V; Stirparo L; Patti C; Sportoletti P; Fresa A; Catania G; Coscia M; Bellesi S; Tedeschi A; et alii...

Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY. in EClinicalMedicine / EClinicalMedicine. 2023 Nov 15;65:102307. doi: 10.1016/j.eclinm.2023.102307. eCollection 2023 Nov.

2023
AOU Città della Salute di Torino
AOU Novara

Claus R; Biderman B; Antic D; Angelopoulou M; Zuchnicka J; Yassin M; Yañez L; Yagci M; Xu Z; Wasik-Szczepanek E; Walewska R; Vukovic V; Vrachiolias G; von Tresckow J; Vitale C; Visentin A; Vassilakopoulos T; Tomic K; Tse E; Spacek M; Tadmor T; Abdelrahman Soliman DS; Smirnova S; Simkovic M; Shen Y; Schiwitza A; Schipani M; Daniel de Deus Santos M; Ruchlemer R; et alii...

Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia. in Therapeutic advances in hematology / Ther Adv Hematol. 2022 Oct 10;13:20406207221127550. doi: 10.1177/20406207221127550. eCollection 2022

2022
AOU Città della Salute di Torino

Laurenti L; Coscia M; Malvisi L; Morelli F; Galitzia A; Curto Pelle A; Cipiciani A; Laureana R; Zamprogna G; Deodato M; Greco A; Borella C; Baratè C; Varettoni M; Gentile M; Reda G; Mauro FR; Sanna A; Chiarenza A; Murru R; Vitale C; Fresa A; Sportoletti P; Visentin A; Del Poeta G; Frustaci AM; Trentin L; Montillo M; Cairoli R; et alii...